Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: Comparison with the Nottingham health profile

Quality of Life Research

Volumn 12, Issue 2, 2003, Pages 117-132

  Doll, Helen ^a,d   Duprat Lomon, Isabelle ^b   Ammerman, Erika ^a   Sagnier, Pierre Philippe ^c  

^a ICON PLC   (United Kingdom)

^b Bayer Pharma SA   (France)

^c Bayer plc UK   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Acute exacerbation of chronic bronchitis; Chronic bronchitis; Health related quality of life; St George's respiratory questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; HUMAN; INSTRUMENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; VALIDATION PROCESS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHITIS, CHRONIC; DEMOGRAPHY; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS;

EID: 0037369768     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022280532276     Document Type: Article

References (62)

1. Epstein RS, Sherwood LM. From outcomes research to disease management: A guide for the perplexed. Ann Intern Med 1996; 124: 832-837.
2. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. Wiley, 2000.
3. Jenkinson C. Health status and mood state in a migraine sample. Int J Social Psychiat 1990; 36: 42-48.
4. Ball P, Make B. Acute exacerbations of chronic bronchitis. An international comparison. Chest 1998; 113: 199S-204S.
5. Williams SJ. Chronic respiratory illness and disability: A critical review of the psychosocial literature. Soc Sci Med 1989; 28: 791-803.
6. Woolcock AJ. Epidemiology of chronic airways disease. Chest 1989; 6: 302-306.
7. Law MR, Morris JK. Why is mortality higher in poorer areas and in more northern areas of England and Wales? J Epidemiol Commun Health 1998; 52: 344-352.
8. Garibaldi RA. Epidemiology of community acquired respiratory tract infections in adults: Incidence, etiology and impact. Am J Med 1995; 78: 32-37.
9. Lehnert H, Schuster H-P. Innere Medizin, Ferdinand Enke Verlag Stuttgart, 1998; 852.
10. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
11. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
12. Moody L. Psychophysiologic correlates of quality of life in chronic bronchitis and emphysema. Western J Nurs Res 1991; 13(3): 336-362.
13. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 162-170.
14. Rutter BM. Some psychological concomitants of chronic bronchitis. Psychol Med 1977; 7: 459-464.
15. Dudley DL, Glaser EM, Jorgenson BN, Logan DL. Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease. Part 1: Psychosocial and psychological considerations. Chest 1980; 77: 413-420.
16. McSweeney AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982; 142: 473-478.
17. McSweeney AJ. Assessing the quality of life in patients with chronic obstructive pulmonary disease. In: NK Wenger, ME Mattson, CP Furberg, J Elinson (eds), Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq, 1984.
18. Morgan MDL. Experience of using the CRQ (Chronic Respiratory Questionnaire). Respiratory Medicine 1991; 85 (Suppl B): 23-24.
19. Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: Conclusions from a randomized controlled trial. Respir Med 1989; 85: 17-21.
20. Fishman AP. Pulmonary rehabilitation research. Am J Crit Care Med 1994; 149: 825-833.
21. Bowling A. Measuring Disease - A review of disease specific quality of life measurement scales. Open University Press, 1995; 149-174.
22. Van Schayck CP, Dompeling E, Rutten MP, Folgering H, van den Boom G, van Weel C. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995; 107: 1199-1205.
23. Taytard A, Cousson F. Symptoms and life of patients with chronic bronchitis. Preliminary results. Rev Pneumol Clin 1996; 52: 379-385.
24. Maille AR, Koning CJ, Zwinderman AH, Willems IN, Dijkman JH, Kaptein AA. The development of the 'Quality-of-life for Respiratory Illness Questionnaire (QOLRIQ)': A disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997; 91: 297-309.
25. DiLorenzo G, Morici G, Drago A, et al. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. Clin Ther 1998; 20: 1130-1148.
26. Del Donno M, Olivieri D. Mucoactive drugs in the management of chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1998; 53: 714-719.
27. Laitinen LA, Koskela K and the Expert Advisory Group. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007. Respir Med 1999; 93: 297-332.
28. Muhlig S, Petermann F. Illness specific data collection on quality of life of patients with asthma and chronic obstructive bronchitis. Rehab Stuttg 1998; 37: XXV-XXXVIII.
29. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993
30. Gift AG, Shepard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: Do women and men differ? J Obstet Gynecol Neonatal Nurs 1999; 28: 201-208.
31. Schlenk EA, Erlen JA, Dunbar-Jacob J, et al. Health-related quality of life in chronic disorders: A comparison across studies using the MOS SF-36. Qual Life Res 1998; 7: 57-65.
32. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: 25-31.
33. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: The St George's Respiratory Questionnaire. Amer Rev Respir Dis 1992; 145: 132-137.
34. Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997; 156: 536-541.
35. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: The Spanish example. Eur Respir J 1996; 9: 1160-1166.
36. Engstrom CP, Persson LO, Larsson S, Sullivan M. Reliability and validity of a Swedish version of the St George's Respiratory Questionnaire. Eur Respir J 1998; 11: 61-66.
37. Monso E, Rosell A, Boner G, et al. The impact of bronchial colonization in the quality of life of patients with chronic, stable bronchitis. Med Clin Barc 1998; 111: 561-564.
38. Monso E, Fiz JM, Izquierdo J, et al. Quality of life in severe chronic obstructive pulmonary disease: Correlation with lung and muscle function. Respir Med 1998; 92: 221-227.
39. Grossman R, Mukherjee J, Vaughan D, et al. A 1-year community-based health economic study of ciproflaxin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: The Canadian Ciprofloxacin Health Economic Study Group. Chest 1998; 113: 131-141.
40. Vernenegre A, Martin J, d'Arco X, et al. Impact on the quality of life of respiratory symptoms and airway obstruction in an agricultural population. Rev Mal Respir 1995; 12: 615-621.
41. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation. Monaldi Arch Chest Dis 1999; 54: 193-196.
42. Jans MP, Schellevis FG, van-Eijk JT. The Nottingham Health Profile: Score distribution, internal consistency and validity in asthma and COPD patients. Qual Life Res 1999; 8: 501-507.
43. Hunt SM, McKenna SP, Williams J. Reliability of a population survey tool for measuring perceived health problems. A study of patients with osteoarthrosis. J Epidemiol Comm Health 1981; 35: 297-300.
44. Hunt SM, McEwen J, McKenna SP, Backett EM, Pope C. Subjective health of patients with peripheral vascular disease. The Practitioner 1982; 226: 133-136.
45. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: Subjective health status and medical consultations. Soc Sci Med 1981; 15: 221-229.
46. Doll HA, Black NA, Flood AB, McPherson K. Criterion validation of the Nottingham Health Profile: Patient views of surgery for Benign Prostatic Hypertrophy. Soc Sci Med 1993; 37: 115-122.
47. Paterson C, Langan CE, McKaig CA, et al. Assessing patient outcomes in acute exacerbations of chronic bronchitis: The measure yourself medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D). Qual Life Res 2000; 9: 521-527.
48. Rychlik R, Pfeil T, Daniel D, Mast O, Thate-Waschke I, Lorenz J. Zur sozioökonomischen relevanz acuter Exazerbationen der chronischen bronchitis in der Bundesrepublik Deutschland. DMW 2001; 126: 353-359.
49. Doll H, Grey-Amante P, Duprat-Lomon I, et al. Quality of life in acute exacerbation of chronic bronchitis: Results from a German population study. Respir Med 2002; 96: 39-51.
50. Anthonsisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
51. Hunt S, McKenna S, McEwen J. The Nottingham Health Profile User's Manual. Manchester: Gaten Research and Consultancy, 1989.
52. St George's Health Status Research Team. The St George's Respiratory Questionnaire Manual. St George's Hospital, London, March 2001.
53. Ware JE, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 1998; 7: 235-244.
54. Alonso J, Anto JM, Gonzales M, Fiz JA, Izquierdo J, Morera J. Measurement of a general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients. Med Care 1992; 30: 125-135.
55. Ketelaars CAJ, Schlösser R, Mostert H, Huyer Abu-Saad H, Halfens RJG, Wouters EFM. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 39-43.
56. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
57. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxemia. Thorax 1996; 51: 44-47.
58. Prieto L. Alonso J, Ferret M, Anto JM. Are results of the SF-36 health survey and the Nottingham Health Profile similar? A comparison in COPD patients. Quality of Life in COPD Study Group. J Clin Epidemiol 1997; 50: 463-473.
59. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995; 107: 187-193.
60. Greenwald HP. The specificity of quality-of-life measures among the seriously ill. Med Care 1987; 25: 642-651.
61. King MT, Dobson A J, Harnett PR. A comparison of two quality-of-life questionnaires for cancer clinical trials: The Functional Living Index-Cancer (FLIC) and the Quality of Life Questionnaire Core Module (QLQ-C30). J Clin Epidemiol 1996; 49: 21-29.
62. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.